HDVvsIBRN
iShares Core High Dividend ETF against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| HDV | IBRN | |
|---|---|---|
| Expense ratio | 0.080% | 0.47% |
| Assets | $15.1B | $7931.50T |
| Net flow, 1 month | +$229M | +$2M |
| Net flow, 1 year | +$1.2B | +$2M |
| Return, YTD | -75.5% | +27.9% |
| Return, 1 year | -75.4% | +68.6% |
| Avg daily volume | 5.4M | 3K |
| Holdings | 81 | 54 |
| Listed | Mar 28, 2011 | Aug 23, 2022 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS